HK Stock MarketDetailed Quotes

02348 DAWNRAYS PHARMA

Watchlist
  • 1.150
  • -0.010-0.86%
Market Closed Apr 19 16:08 CST
1.73BMarket Cap4.79P/E (TTM)

DAWNRAYS PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
-9.90%1.15B
4.24%649.92M
9.66%1.28B
2.45%623.48M
13.75%1.17B
24.46%608.59M
7.82%1.02B
-0.36%488.99M
0.11%950.01M
-1.24%490.75M
Operating income
-9.90%1.15B
4.24%649.92M
9.66%1.28B
2.45%623.48M
13.75%1.17B
24.46%608.59M
7.82%1.02B
-0.36%488.99M
0.11%950.01M
-1.24%490.75M
Cost of sales
-1.09%-509.63M
-24.60%-288.07M
-4.18%-504.13M
1.83%-231.2M
-2.17%-483.89M
-5.01%-235.5M
-14.36%-473.63M
-14.61%-224.26M
-17.02%-414.14M
-6.20%-195.68M
Operating expenses
-1.09%-509.63M
-24.60%-288.07M
-4.18%-504.13M
1.83%-231.2M
-2.17%-483.89M
-5.01%-235.5M
-14.36%-473.63M
-14.61%-224.26M
-17.02%-414.14M
-6.20%-195.68M
Gross profit
-17.07%641.52M
-7.76%361.85M
13.55%773.55M
5.14%392.28M
23.72%681.26M
40.93%373.09M
2.76%550.65M
-10.28%264.74M
-9.94%535.87M
-5.63%295.08M
Selling expenses
-3.02%-147.05M
12.58%-69M
-30.91%-142.73M
-9.23%-78.93M
-99.79%-109.03M
-83.06%-72.26M
35.66%-54.57M
24.63%-39.48M
20.63%-84.81M
2.87%-52.37M
Administrative expenses
7.25%-113.21M
-9.20%-59.18M
-3.96%-122.06M
-0.85%-54.2M
-7.49%-117.41M
-6.87%-53.74M
-12.50%-109.22M
-13.25%-50.28M
-16.71%-97.09M
-15.15%-44.4M
Research and development expenses
-14.26%-90.81M
-2.67%-30.76M
-18.57%-79.48M
-6.45%-29.96M
-15.68%-67.03M
-22.52%-28.15M
---57.94M
---22.97M
----
----
Operating interest expense
----
-48.00%-333K
----
-46.10%-225K
86.72%-641K
---154K
9.06%-4.83M
----
-360.85%-5.31M
----
Special items of operating profit
131.82%165.52M
746.72%144.93M
-27.57%71.4M
81.90%17.12M
279.30%98.59M
-59.82%9.41M
214.31%25.99M
585.35%23.42M
-89.28%-22.74M
55.88%-4.83M
Operating profit
-8.93%455.98M
41.22%347.51M
3.08%500.68M
7.84%246.08M
38.76%485.74M
30.09%228.2M
7.41%350.07M
-9.33%175.43M
-16.82%325.92M
-7.45%193.48M
Financing cost
-166.58%-989K
----
---371K
----
----
----
----
-253.62%-3.56M
----
---1.01M
Share of profits of associates
33.88%-40.93M
0.95%-20.3M
-33.36%-61.91M
-19.69%-20.49M
-147.29%-46.42M
-71.91%-17.12M
-58.69%-18.77M
-80.63%-9.96M
15.80%-11.83M
-59.00%-5.51M
Earning before tax
-5.55%414.06M
45.05%327.21M
-0.21%438.41M
6.87%225.59M
32.61%439.32M
30.37%211.08M
5.48%331.3M
-13.40%161.91M
-16.86%314.09M
-9.06%186.96M
Tax
-10.70%-91.39M
-35.85%-73.04M
3.06%-82.56M
-18.45%-53.77M
-28.05%-85.16M
-32.13%-45.39M
-13.22%-66.51M
5.99%-34.35M
20.43%-58.74M
7.22%-36.54M
After-tax profit from continuing operations
-9.33%322.67M
47.92%254.17M
0.48%355.85M
3.70%171.83M
33.75%354.16M
29.90%165.69M
3.70%264.79M
-15.20%127.55M
-15.99%255.36M
-9.49%150.42M
Earning after tax
-9.33%322.67M
47.92%254.17M
0.48%355.85M
3.70%171.83M
33.75%354.16M
29.90%165.69M
3.70%264.79M
-15.20%127.55M
-15.99%255.36M
-9.49%150.42M
Minority profit
-51.09%-3.33M
-1,173.33%-1.77M
45.01%-2.21M
117.28%165K
-20.23%-4.01M
55.35%-955K
-4,409.46%-3.34M
---2.14M
---74K
----
Profit attributable to shareholders
-8.95%326M
49.10%255.94M
-0.03%358.06M
3.01%171.66M
33.58%358.18M
28.49%166.65M
4.97%268.13M
-13.78%129.69M
-15.97%255.43M
-9.49%150.42M
Basic earnings per share
-9.00%0.2174
48.95%0.1707
-0.13%0.2389
2.96%0.1146
37.79%0.2392
33.13%0.1113
7.09%0.1736
-11.91%0.0836
-15.40%0.1621
-9.45%0.0949
Diluted earnings per share
-8.94%0.217
48.91%0.1702
0.34%0.2383
3.07%0.1143
36.89%0.2375
32.66%0.1109
7.03%0.1735
-11.91%0.0836
-15.40%0.1621
-9.45%0.0949
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover -9.90%1.15B4.24%649.92M9.66%1.28B2.45%623.48M13.75%1.17B24.46%608.59M7.82%1.02B-0.36%488.99M0.11%950.01M-1.24%490.75M
Operating income -9.90%1.15B4.24%649.92M9.66%1.28B2.45%623.48M13.75%1.17B24.46%608.59M7.82%1.02B-0.36%488.99M0.11%950.01M-1.24%490.75M
Cost of sales -1.09%-509.63M-24.60%-288.07M-4.18%-504.13M1.83%-231.2M-2.17%-483.89M-5.01%-235.5M-14.36%-473.63M-14.61%-224.26M-17.02%-414.14M-6.20%-195.68M
Operating expenses -1.09%-509.63M-24.60%-288.07M-4.18%-504.13M1.83%-231.2M-2.17%-483.89M-5.01%-235.5M-14.36%-473.63M-14.61%-224.26M-17.02%-414.14M-6.20%-195.68M
Gross profit -17.07%641.52M-7.76%361.85M13.55%773.55M5.14%392.28M23.72%681.26M40.93%373.09M2.76%550.65M-10.28%264.74M-9.94%535.87M-5.63%295.08M
Selling expenses -3.02%-147.05M12.58%-69M-30.91%-142.73M-9.23%-78.93M-99.79%-109.03M-83.06%-72.26M35.66%-54.57M24.63%-39.48M20.63%-84.81M2.87%-52.37M
Administrative expenses 7.25%-113.21M-9.20%-59.18M-3.96%-122.06M-0.85%-54.2M-7.49%-117.41M-6.87%-53.74M-12.50%-109.22M-13.25%-50.28M-16.71%-97.09M-15.15%-44.4M
Research and development expenses -14.26%-90.81M-2.67%-30.76M-18.57%-79.48M-6.45%-29.96M-15.68%-67.03M-22.52%-28.15M---57.94M---22.97M--------
Operating interest expense -----48.00%-333K-----46.10%-225K86.72%-641K---154K9.06%-4.83M-----360.85%-5.31M----
Special items of operating profit 131.82%165.52M746.72%144.93M-27.57%71.4M81.90%17.12M279.30%98.59M-59.82%9.41M214.31%25.99M585.35%23.42M-89.28%-22.74M55.88%-4.83M
Operating profit -8.93%455.98M41.22%347.51M3.08%500.68M7.84%246.08M38.76%485.74M30.09%228.2M7.41%350.07M-9.33%175.43M-16.82%325.92M-7.45%193.48M
Financing cost -166.58%-989K-------371K-----------------253.62%-3.56M-------1.01M
Share of profits of associates 33.88%-40.93M0.95%-20.3M-33.36%-61.91M-19.69%-20.49M-147.29%-46.42M-71.91%-17.12M-58.69%-18.77M-80.63%-9.96M15.80%-11.83M-59.00%-5.51M
Earning before tax -5.55%414.06M45.05%327.21M-0.21%438.41M6.87%225.59M32.61%439.32M30.37%211.08M5.48%331.3M-13.40%161.91M-16.86%314.09M-9.06%186.96M
Tax -10.70%-91.39M-35.85%-73.04M3.06%-82.56M-18.45%-53.77M-28.05%-85.16M-32.13%-45.39M-13.22%-66.51M5.99%-34.35M20.43%-58.74M7.22%-36.54M
After-tax profit from continuing operations -9.33%322.67M47.92%254.17M0.48%355.85M3.70%171.83M33.75%354.16M29.90%165.69M3.70%264.79M-15.20%127.55M-15.99%255.36M-9.49%150.42M
Earning after tax -9.33%322.67M47.92%254.17M0.48%355.85M3.70%171.83M33.75%354.16M29.90%165.69M3.70%264.79M-15.20%127.55M-15.99%255.36M-9.49%150.42M
Minority profit -51.09%-3.33M-1,173.33%-1.77M45.01%-2.21M117.28%165K-20.23%-4.01M55.35%-955K-4,409.46%-3.34M---2.14M---74K----
Profit attributable to shareholders -8.95%326M49.10%255.94M-0.03%358.06M3.01%171.66M33.58%358.18M28.49%166.65M4.97%268.13M-13.78%129.69M-15.97%255.43M-9.49%150.42M
Basic earnings per share -9.00%0.217448.95%0.1707-0.13%0.23892.96%0.114637.79%0.239233.13%0.11137.09%0.1736-11.91%0.0836-15.40%0.1621-9.45%0.0949
Diluted earnings per share -8.94%0.21748.91%0.17020.34%0.23833.07%0.114336.89%0.237532.66%0.11097.03%0.1735-11.91%0.0836-15.40%0.1621-9.45%0.0949
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg